Donor lymphocyte infusion for post-transplant relapse of hodgkin's lymphoma

Haematologica

Volumn 85, Issue 7, 2000, Pages 780-781

  De Rosa, G ^a   Pezzullo, L ^a   Scarpato, N ^a   Selleri, C ^a   Lucania, A ^a   Rotoli, B ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BONE MARROW RESCUE; CASE REPORT; HODGKIN DISEASE; HUMAN; HUMAN CELL; LYMPHOCYTE TRANSFUSION; MALE; ORGAN DONOR; RELAPSE;

ADULT; BLOOD DONORS; BONE MARROW TRANSPLANTATION; HODGKIN DISEASE; HUMANS; IMMUNOTHERAPY, ADOPTIVE; LYMPHOCYTE TRANSFUSION; MALE; RECURRENCE; SALVAGE THERAPY; TOXOPLASMOSIS, CEREBRAL; TRANSPLANTATION CONDITIONING;

EID: 0033868850     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. A five drug regimen (VEBEP) followed by involved field radiotherapy in the treatment of Hodgkin's disease
2. G-CSF stimulated donor peripheral blood infusions as immunotherapy in patients with hematologic malignancies relapsing after allogeneic transplantation
3. +- enriched donor lymphocyte infusions in a case of pure red cell aplasia and late graft failure after major ABO-incompatible bone marrow transplantation
4. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: Current practice in Europe in 1996 and proposals for an operational classification. Accreditation Sub-Committee of the European Group for Blood and Marrow Transplantation (EBMT)
5. Management of relapse
6. Treatment of relapse after allogeneic BMT with donor leukocyte infusions in 16 patients